DE60327442D1 - Antikörperkonstruktion unter verwendung einer mrl/lpr-maus - Google Patents
Antikörperkonstruktion unter verwendung einer mrl/lpr-mausInfo
- Publication number
- DE60327442D1 DE60327442D1 DE60327442T DE60327442T DE60327442D1 DE 60327442 D1 DE60327442 D1 DE 60327442D1 DE 60327442 T DE60327442 T DE 60327442T DE 60327442 T DE60327442 T DE 60327442T DE 60327442 D1 DE60327442 D1 DE 60327442D1
- Authority
- DE
- Germany
- Prior art keywords
- mrl
- lpr mouse
- antibody
- antibody construction
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2002/008998 WO2004022595A1 (ja) | 2002-09-04 | 2002-09-04 | MRL/lprマウスを用いた抗体の作製 |
PCT/JP2003/011319 WO2004022754A1 (ja) | 2002-09-04 | 2003-09-04 | MRL/lprマウスを用いた抗体の作製 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60327442D1 true DE60327442D1 (de) | 2009-06-10 |
Family
ID=31972305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60327442T Expired - Lifetime DE60327442D1 (de) | 2002-09-04 | 2003-09-04 | Antikörperkonstruktion unter verwendung einer mrl/lpr-maus |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060246550A1 (de) |
EP (3) | EP1849867A1 (de) |
JP (1) | JP4571496B2 (de) |
AT (1) | ATE430198T1 (de) |
AU (2) | AU2002328429A1 (de) |
DE (1) | DE60327442D1 (de) |
WO (2) | WO2004022595A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006006693A1 (ja) | 2004-07-09 | 2006-01-19 | Chugai Seiyaku Kabushiki Kaisha | 抗グリピカン3抗体 |
CN101014367B (zh) | 2004-08-24 | 2012-07-04 | 中外制药株式会社 | 使用抗磷脂酰肌醇蛋白聚糖-3抗体的辅助疗法 |
CA2585196C (en) | 2004-10-26 | 2015-01-06 | Chugai Seiyaku Kabushiki Kaisha | Anti-glypican 3 antibody having modified sugar chain |
US20070087005A1 (en) | 2005-10-14 | 2007-04-19 | Lazar Gregory A | Anti-glypican-3 antibody |
JP2008110943A (ja) * | 2006-10-31 | 2008-05-15 | Niigata Univ | モノクローナル抗体の作成方法 |
ES2562790T3 (es) | 2007-07-17 | 2016-03-08 | E. R. Squibb & Sons, L.L.C. | Anticuerpos monoclonales contra Glipicano-3 |
CN107973851A (zh) | 2010-11-30 | 2018-05-01 | 中外制药株式会社 | 与多分子的抗原重复结合的抗原结合分子 |
WO2012073985A1 (ja) | 2010-11-30 | 2012-06-07 | 中外製薬株式会社 | 細胞傷害誘導治療剤 |
WO2012133782A1 (ja) | 2011-03-30 | 2012-10-04 | 中外製薬株式会社 | 抗原結合分子の血漿中滞留性と免疫原性を改変する方法 |
CN103974721A (zh) | 2011-09-30 | 2014-08-06 | 中外制药株式会社 | 促进抗原消除的抗原结合分子 |
KR102239138B1 (ko) | 2011-09-30 | 2021-04-12 | 추가이 세이야쿠 가부시키가이샤 | 표적 항원에 대한 면역응답을 유도하는 항원 결합 분자 |
JP6271251B2 (ja) | 2011-10-05 | 2018-01-31 | 中外製薬株式会社 | 糖鎖受容体結合ドメインを含む抗原の血漿中からの消失を促進する抗原結合分子 |
US20160046693A1 (en) | 2012-02-24 | 2016-02-18 | Chugai Seiyaku Kabushiki Kaisha | Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIB |
KR20150016579A (ko) | 2012-05-30 | 2015-02-12 | 추가이 세이야쿠 가부시키가이샤 | 표적 조직 특이적 항원 결합 분자 |
TWI693073B (zh) | 2012-12-21 | 2020-05-11 | 日商中外製藥股份有限公司 | 對gpc3標的治療劑療法為有效之患者投與的gpc3標的治療劑 |
WO2014144170A1 (en) * | 2013-03-15 | 2014-09-18 | The Cleveland Clinic Foundation | In-vitro method for monoclonal antibody production using non-human act1 -deficient mice |
AU2014358191B2 (en) | 2013-12-04 | 2020-12-24 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules |
EP3141603A4 (de) | 2014-05-08 | 2017-12-27 | Chugai Seiyaku Kabushiki Kaisha | Gpc3-anzielendes therapeutikum für die verabreichung an einen mittels einer therapie mit dem gpc3-anzielenden therapeutikum behandelten patienten |
MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
EP3318879B1 (de) | 2015-07-01 | 2020-10-21 | Chugai Seiyaku Kabushiki Kaisha | Verabreichung eines gegen gpc3 gerichteten therapeutikums an einen patienten mit bestätigter wirksamkeit des gegen gpc3 gerichteten therapeutikums |
SG11201807936VA (en) | 2016-03-14 | 2018-10-30 | Chugai Pharmaceutical Co Ltd | Cell injury inducing therapeutic drug for use in cancer therapy |
TW202235438A (zh) | 2016-11-28 | 2022-09-16 | 日商中外製藥股份有限公司 | 能夠調節配體結合活性的配體結合分子 |
AU2018376309A1 (en) | 2017-11-28 | 2020-06-25 | Chugai Seiyaku Kabushiki Kaisha | Ligand-binding molecule having adjustable ligand-binding activity |
WO2019230868A1 (ja) | 2018-05-30 | 2019-12-05 | 中外製薬株式会社 | 単ドメイン抗体含有リガンド結合分子 |
EP3943108A4 (de) | 2019-03-19 | 2023-01-04 | Chugai Seiyaku Kabushiki Kaisha | Antigen-bindendes molekül mit antigen-bindender domäne mit veränderlicher bindungsaktivität gegenüber antigen in abhängigkeit von mta und bibliothek zur gewinnung der antigen-bindenden domäne |
CN114127277A (zh) | 2019-06-05 | 2022-03-01 | 中外制药株式会社 | 蛋白酶底物和包含蛋白酶切割序列的多肽 |
AU2020288499A1 (en) | 2019-06-05 | 2022-01-27 | Chugai Seiyaku Kabushiki Kaisha | Antibody cleavage site-binding molecule |
WO2021100715A1 (ja) * | 2019-11-18 | 2021-05-27 | 住友化学株式会社 | 抗体の作製方法 |
EP4197545A1 (de) | 2020-07-31 | 2023-06-21 | Chugai Seiyaku Kabushiki Kaisha | Pharmazeutische zusammensetzung mit einer zelle zur expression eines chimären rezeptors |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4965198A (en) * | 1985-12-24 | 1990-10-23 | Konica Corporation | Monoclonal antibody and method of manufacturing hybridoma producing the same |
JPH0787798B2 (ja) * | 1987-04-27 | 1995-09-27 | コニカ株式会社 | モノクロ−ナル抗体の製造方法 |
JPH0722518B2 (ja) * | 1987-06-04 | 1995-03-15 | コニカ株式会社 | モノクローナル抗体 |
JPH0776600B2 (ja) | 1991-01-28 | 1995-08-16 | 未来工業株式会社 | 流体管の二重配管における消音構造及びそれに使用する介在材 |
US5976835A (en) * | 1992-03-19 | 1999-11-02 | The Rockefeller University | Nucleic acids encoding receptor recognition factor Stat1α and Stat1β, and methods of use thereof |
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
US5756361A (en) * | 1992-12-17 | 1998-05-26 | Metra Biosystems, Inc. | Screening method for periodontal disease |
US5641488A (en) * | 1993-04-01 | 1997-06-24 | National Jewish Center For Immunology And Respiratory Medicine | Method for producing an antibody to a chosen antigen |
JPH0776600A (ja) * | 1993-07-14 | 1995-03-20 | Kao Corp | モノクローナル抗体及びこれを産生するハイブリドーマ |
CA2194907A1 (en) | 1994-07-13 | 1996-02-01 | Kouji Matsushima | Reshaped human antibody against human interleukin-8 |
CA2215905A1 (en) * | 1995-03-20 | 1996-09-26 | Sumitomo Electric Industries, Ltd. | Monoclonal antibody reacting specifically with fas ligand and process for producing the same |
KR100847441B1 (ko) | 1996-09-26 | 2008-07-21 | 츄가이 세이야꾸 가부시키가이샤 | 인간의 부갑상선 호르몬 관련 펩티드에 대한 항체 |
WO1999037764A2 (en) * | 1998-01-27 | 1999-07-29 | Vlaams Interuniversitair Instituut Voor Biotechnologie | New members of the glypican gene family |
RU2319969C2 (ru) * | 2002-05-23 | 2008-03-20 | Саннибрук Энд Вуменз Колледж Хелс Сайнсиз Сентре | Способ диагностики гепатоцеллюлярной карциномы |
-
2002
- 2002-09-04 WO PCT/JP2002/008998 patent/WO2004022595A1/ja not_active Application Discontinuation
- 2002-09-04 AU AU2002328429A patent/AU2002328429A1/en not_active Abandoned
-
2003
- 2003-09-04 AT AT03794237T patent/ATE430198T1/de not_active IP Right Cessation
- 2003-09-04 WO PCT/JP2003/011319 patent/WO2004022754A1/ja active Application Filing
- 2003-09-04 EP EP07006218A patent/EP1849867A1/de not_active Withdrawn
- 2003-09-04 EP EP03794237A patent/EP1541686B1/de not_active Expired - Lifetime
- 2003-09-04 AU AU2003261942A patent/AU2003261942A1/en not_active Abandoned
- 2003-09-04 DE DE60327442T patent/DE60327442D1/de not_active Expired - Lifetime
- 2003-09-04 JP JP2004534161A patent/JP4571496B2/ja not_active Expired - Fee Related
- 2003-09-04 US US10/526,372 patent/US20060246550A1/en not_active Abandoned
- 2003-09-04 EP EP09003728A patent/EP2075257B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2002328429A1 (en) | 2004-03-29 |
WO2004022754A1 (ja) | 2004-03-18 |
US20060246550A1 (en) | 2006-11-02 |
EP2075257B1 (de) | 2012-08-08 |
EP1849867A1 (de) | 2007-10-31 |
EP1541686B1 (de) | 2009-04-29 |
EP1541686A4 (de) | 2005-12-21 |
JPWO2004022754A1 (ja) | 2005-12-22 |
EP1541686A1 (de) | 2005-06-15 |
WO2004022595A1 (ja) | 2004-03-18 |
ATE430198T1 (de) | 2009-05-15 |
EP2075257A1 (de) | 2009-07-01 |
JP4571496B2 (ja) | 2010-10-27 |
AU2003261942A1 (en) | 2004-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60327442D1 (de) | Antikörperkonstruktion unter verwendung einer mrl/lpr-maus | |
DE60131456D1 (de) | Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern | |
ATE490323T1 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
ATE391781T1 (de) | Transgenes tier welches das trunkierte alzheimer tau protein exprimiert | |
ATE323510T1 (de) | Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen | |
CY1114944T1 (el) | Σταθεροποιημενα αλφα ελικοειδη πεπτιδια και χρησεις αυτων | |
ATE401390T1 (de) | Zytokin (zcytor17-ligand) | |
BR9710665A (pt) | Compostos que promovem o desenvolvimento do tecido | |
NO961115D0 (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
DK1351707T3 (da) | Fremgangsmåder til behandling af autoimmunsygdomme hos et individ og in vitro-diagnostiske analyser | |
WO2002090499A3 (en) | ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME | |
ATE534909T1 (de) | Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren | |
WO2002094009A3 (en) | Methods for selecting and producing animals having a predicted level of immune response | |
DE60329070D1 (de) | Antikörper gegen den fibroblastenwachstumsfaktor 23 | |
DE69938015D1 (de) | Neue G Protein-gekoppelte Rezeptorproteine | |
DE60335726D1 (de) | Chromoprotein und fluoroproteine | |
BR9915732A (pt) | Geração de anticorpos usando-se vacinação de polinucleotìdeo em espécie de ave | |
DK0914419T3 (da) | Transgene mus i stand til at udtrykke leukæmiinhiberende faktor | |
ATE517629T1 (de) | Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems | |
ATE212066T1 (de) | Verwendung einer genveränderung im gen für die humane g-protein beta3-untereinheit zur diagnostik von erkrankungen | |
AU2001232275A1 (en) | Novel collagen-like protein clac, precursor thereof and genes encoding the same | |
NZ334739A (en) | Method of screening animals resistant or susceptible to diseases caused by intracellular parasites by analysing the bovine Nramp1 DNA sequence | |
DE50308032D1 (de) | Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung | |
WO2003082206A3 (en) | Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses | |
NO20052525L (no) | Spleisevariant av humant hypofyseveksthormon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |